Market Trends of United States Blister Packaging Industry
This section covers the major market trends shaping the US Blister Packaging Market according to our research experts:
Pharmaceutical Sector is Expected to Witness Significant Growth
- The pharmaceutical sector poses a different set of demands for blister packaging solutions concerning insulation from external surroundings, cost-effectiveness, high levels of protection, and the ease of handling and retaining the effectiveness of the medicine. These packs are uniquely suited to meet stringent regulations and are highly valued for protective properties, cost-effectiveness, adaptability, and the pharmaceutical and packaging industry's requirements.
- Adherence is improved when medicines are blister packaged because consumers can track their medications and dosage. The unit dosage feature of blisters reduces the risk of incorrect dosing.
- The retail-level preparation of prescription drugs is troubling pharmaceutical technicians or pharmacists. The administration of medicines in the open atmosphere of the supermarket and drug store may negatively affect sensitive medication when they are transferred from container to container. Blister packaging can guarantee the process of distribution directly to the customer.
- Protecting product integrity continues to be the primary goal of pharmaceutical packaging. Still, there is continued work on cost reduction in the packaging process in all areas of the packaging industry.
- For instance, Amcor provides Polybar barrier film product families that cover a wide range of moisture barriers while also providing good crush resistance to ensure the best protection for pharmaceutical applications such as tablets and capsules. It uses materials such as Aclar, COC, PE, PVC, and PVdc.
- Further, pharmaceutical companies catering to solid dose divisions are investing in expanding manufacturing facilities in the United States. Recently, Aphena Pharma Solutions announced the expansion of the solid dose division in Cookeville, Tennessee. The company has aimed to equip the facility with 24 high-speed bottling lines and eight thermoform blister packaging lines. This indicates the demand for blister packaging in the region.
Growing Geriatric Population and Prevalence of Diseases
- The country is prone to various diseases, and multiple CDMOs and CMOs have established a presence in the United States to introduce new APIs for solid drugs that help cure multiple diseases. This is expected to drive blister packaging in the country.
- For instance, according to the Centers for Disease Control and Prevention, new cases of Tuberculosis were witnessed along with the rapid spread of COVID-19. Alaska and Huwai recorded 7.5% and 6.5% of cases per 100,000 population in the country.
- Moreover, owing to the growing population in the country and rising diseases, pharmaceutical companies have taken the opportunity to expand manufacturing facilities for the solid dose, which has increased demand for blister packaging in the country.
- With the increasing number of diseases in the country, the expenditure on medicine in the United States is also growing. For example, according to data published by IQVIA in April 2022, the total amount of money spent on drugs reached approximately USD 574 billion in 2021. Spending increased annually between 2012 and 2021, rising by USD 255 billion.